Health

Upfront T-DXd Combo Nearly Doubles PFS in HER2-Positive Breast Cancer

TribeNews
By TribeNews 3 Views Add a Comment
0 Min Read
Upfront T-DXd Combo Nearly Doubles PFS in HER2-Positive Breast Cancer

MedPage Today) — At the recent American Society of Clinical Oncology (ASCO) annual meeting, interim results from the DESTINY-Breast09 trial highlighted a potential shift in frontline treatment for metastatic HER2-positive breast cancer. The combination…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app